Contribution of Immunohistochemical Profile in Assessing Histological Grade of Endometrial Cancer

  1. MARCOS BALLESTER1,2,4
  1. 1Departement of Obstetrics and Gynecology, Tenon University Hospital, APHP, Paris, France
  2. 2Institut Universitaire de Cancérologie, Université Pierre et Marie Curie, Paris, France
  3. 3UMRS 938, Université Pierre et Marie Curie, Paris, France
  4. 4ER2 UPMC, Université Pierre et Marie Curie, Paris, France
  1. Correspondence to: Marcos Ballester, MD, Departement of Obstetrics and Gynecology, Tenon University Hospital, APHP, Paris, France. Tel: +33 156016007, e-mail: marcos.ballester{at}tnn.aphp.fr

Abstract

Background: The aim of this study was to correlate immunostaining expression profiles with histological grade using a predictive model. Patients and Methods: Samples were collected from 69 women with endometrial cancer. Immunostaining for expression of estrogen receptor (ER), progesteron receptor (PR), Ki67 and p53 in grade 1 or 2 and grade 3 tumors were compared. After determining optimal immunostaining cut-offs, we built a model to predict the final histological grade. Results: Higher immunostaining of ER and PR was found in grade 1 or 2 (p=0.01) compared with grade 3 tumors. Higher immunostaining for Ki67 (p<0.0001) and p53 (p<0.001) was found in grade 3 than in grade 1 or 2 tumors. The recursive partitioning model predicted a grade 1 or 2 tumor in 98% of cases when Ki67 and p53 were underexpressed. The mis-classification rate was 13%. Conclusion: Our results show that integrating immunohistochemical profiles in a simple predictive model could help predict the final histological grade of endometrial tumors, especially for grade 1 or 2.

  • Received February 16, 2013.
  • Revision received March 20, 2013.
  • Accepted March 21, 2013.
| Table of Contents